Falling between the cracks: a case of amiodarone toxicity

Mackenzie, Constanze; Syed, Jaffer; Pollak, Timothy; Koren, Gideon
September 2011
CMAJ: Canadian Medical Association Journal;9/6/2011, Vol. 183 Issue 12, p1393
Academic Journal
Case Study
The article presents a case study of a 64-year-old woman who had a history of nausea, diarrhea, and vomiting. She was found having multisystem amiodarone toxicity, which includes pulmonary, hepatic, and thyroid toxicity. The article discusses amiodarone toxicity, which is induced by the pharmacodynamic and pharmacokinetic properties of the drug itself.


Related Articles

  • Methodological Issues in Pharmacokinetic-Pharmacodynamic Modelling. Bellissant, E.; Sébille, V.; Paintaud, G. // Clinical Pharmacokinetics;1998, Vol. 35 Issue 2, p151 

    This article presents the theoretical and practical aspects involved in the design and analysis of pharmacokinetic-pharmacodynamic modelling studies. The main features of the protocol of pharmacokinetic-pharmacodynamic studies are discussed with special focus on experimental designs in relation...

  • Anatomical-Physiological Approaches in Pharmacokinetics and Pharmacodynamics. Mather, L.E. // Clinical Pharmacokinetics;Oct2001, Vol. 40 Issue 10, p707 

    Use of an anatomical-physiological approach allows an investigator an alternative to regarding the whole body as a ‘black box’ producing biofluid specimens for drug assay, and then blindly applying a formula-driven mathematical approach to determine the pharmacokinetics and...

  • Pharmacokinetics in the infant Jusko, William J.; Milsap, Rebecca L. // Environmental Health Perspectives Supplements;1994 Supplement 11, Vol. 102, p107 

    No abstract available.

  • Phase I study of Carzelesin (U-80,244) given (4-weekly) by intravenous bolus schedule. Awada, A; Tellingen, O Van; Manen, L Van; Kerger, J; Groot, Y; Wanders, J; Verweij, J // British Journal of Cancer;3/15/99, Vol. 79 Issue 9/10, p1454 

    Carzelesin is a cyclopropylpyrroloindole analogue which acts as a DNA-sequence-specific alkylating agent. In this phase I study, Carzelesin was given as a 4-weekly 10 min IV infusion to 51 patients with advanced solid tumours. Patients received a median of two courses (range 1-5) at one of nine...

  • Poster Session II (PII 1-84)Displayed 8:00 am � 3:00 pmAttended 8:00 am � 9:30 am.  // Clinical Pharmacology & Therapeutics;Feb2010 Supplement 1, Vol. 87, pS39 

    The article presents several abstracts of papers on clinical pharmacology which include closet smoking, a potentially unrecognized risk for amiodarone pulmonary toxicity through P450 induction, the effect of continuous positive airway pressure on drug metabolism in obstructive sleep apnea...

  • Changes to journal of pharmacokinetics and pharmacodynamics. Jusko, William // Journal of Pharmacokinetics & Pharmacodynamics;Feb2012, Vol. 39 Issue 1, p1 

    The article discusses the changes to "The Journal of Pharmacokinetics and Pharmacodynamics," at the start of year 2012.

  • Butcher's Broom: Evidence-Based Phytotherapy for Venous Conditions. Bone, Kerry // Townsend Letter for Doctors & Patients;Aug/Sep2003, Issue 241/242, p66 

    Provides information on Ruscus aculeatus. Literature review on the pharmacodynamics of Ruscus aculeatus; Oral bioavailability; Adverse reactions related to the oral intake of Ruscus aculeatus.

  • Pharmacokinetics and Pharmacodynamics of Intramuscular Dermatan Sulfate Revisited: A Single- and Repeated-Dose Study in Healthy Volunteers. Saivin, Sylvie; Cambus, Jean-Pierre; Thalamas, Claire; Lau, Geneviève; Boneu, Bernard; Houin, Georges; Gianese, Francesco // Clinical Drug Investigation;2003, Vol. 23 Issue 8, p533 

    Objective: To assess the pharmacokinetics and effects on blood coagulation of dermatan sulfate (DS), a glycosaminoglycan with antithrombotic properties, following intravenous and single and repeated intramuscular administrations. The mean molecular weight of DS is currently 22kD, i.e. 5kD lower...

  • Pharmacokinetic-Pharmacodynamic Modelling of the Antipyretic Effect of Two Oral Formulations of Ibuprofen. Trocóniz, I.F.; Armenteros, S.; Planelles, M.V.; Benítez, J.; Calvo, R.; Domínguez, R. // Clinical Pharmacokinetics;2000, Vol. 38 Issue 6, p505 

    Objective: To analyse the population pharmacokinetic-pharmacodynamic relationships of racemic ibuprofen administered in suspension or as effervescent granules with the aim of exploring the effect of formulation on the relevant pharmacodynamic parameters. Design: The pharmacokinetic model was...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics